Georgia Tech and Emory University Researchers Use Blood Testing to Predict Level of Enzymes That Facilitate Disease Progression  
11/2/2012 7:46:33 AM

Predicting how atherosclerosis, osteoporosis or cancer will progress or respond to drugs in individual patients is difficult. In a new study, researchers took another step toward that goal by developing a technique able to predict from a blood sample the amount of cathepsins—protein-degrading enzymes known to accelerate these diseases—a specific person would produce.